Transfusion Medicine and Blood Safety
Search documents
Cerus's Record 2025 Sets It Up For Another Leg Higher
Seeking Alpha· 2026-03-05 14:44
Company Overview - Cerus Corporation (CERS) is a medical technology company focused on transfusion medicine and blood safety, utilizing its proprietary INTERCEPT Blood System, which includes illuminator devices and single-use processing [1] Technology and Innovation - The INTERCEPT Blood System is designed to enhance blood safety by inactivating pathogens in blood products, thereby reducing the risk of transfusion-transmitted infections [1]